Author, year |
Age/sex |
Spinal level |
Symptoms at presentation |
MRI findings |
Serum ACE |
Pathology findings |
Outcome at the time of follow-up |
Follow-up (months) |
T1 |
T2 |
Gd |
Beros et al., 2008 [15] |
40/M |
T9-12 |
Impaired ambulation, loss of temperature sensation, loss of touch sensation, paresthesia, urinary incontinence |
Thickened cord |
Hyperintense, cord edema |
Enhancement |
Elevated |
Noncaseating granulomas with central epitheliod cells, few Langhans cells, and peripheral lymphocytes |
Rapid clinical improvement |
2.5 |
Caneparo et al., 2007 [14] |
61/M |
T5-T6 |
Numbness, urinary incontinence |
NR |
Hyperintense |
Enhancement |
780 U/l |
NR |
Unchanged sensory symptoms |
12 |
Duhon et al., 2012 [16] |
48/M |
T10-T11 |
Back pain, Lhermitte pain, numbness, paresthesia, weakness |
NR |
Hyperintense |
Enhancement |
2 U/l |
Perivascular noncaseating granulomas with lymphocytic infiltration |
Full strength, mild numbness |
18 |
Wang, 1999 [13] |
66/F |
T10-T11 |
Numbness, urinary incontinence, urinary retention, weakness |
Normal |
Normal |
Enhancement |
22 IU/l |
Noncaseating granulomatous inflammation with perivascular lymphocytic infiltration |
Mortality (UTI, sepsis) |
1 |